The effect of thymoquinone treatment on the combined renal and pulmonary toxicity of cisplatin and diesel exhaust particles

Experimental Biology and Medicine

Volumn 240, Issue 12, 2015, Pages 1698-1707

  Ali, Badreldin H ^a   Al Za'abi, Mohammed ^a   Shalaby, Asem ^a   Manoj, Priyadarsini ^a   Waly, Mostafa I ^a   Yasin, Javed ^b   Fahim, Mohamed ^b   Nemmar, Abderrahim ^b  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Cisplatin; diesel exhaust particle; nephrotoxicity; rats; thymoquinone

Indexed keywords

ALPHA N ACETYLGLUCOSAMINIDASE; C REACTIVE PROTEIN; CISPLATIN; CORN OIL; CREATININE; DIESEL EXHAUST PARTICLE; INTERLEUKIN 6; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; THYMOQUINONE; TOXIC SUBSTANCE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; ANTIOXIDANT; BENZOQUINONE DERIVATIVE; EXHAUST GAS; PARTICULATE MATTER;

AIR POLLUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXHAUST GAS; FLUID INTAKE; KIDNEY TUBULE NECROSIS; LUNG TOXICITY; MALE; NEPHROTOXICITY; NONHUMAN; RAT; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; BLOOD; DRUG EFFECTS; DRUG INTERACTION; KIDNEY; LUNG; PARTICULATE MATTER; TOXICITY; WISTAR RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BENZOQUINONES; C-REACTIVE PROTEIN; CISPLATIN; DRUG INTERACTIONS; INTERLEUKIN-6; KIDNEY; LUNG; MALE; PARTICULATE MATTER; RATS; RATS, WISTAR; VEHICLE EMISSIONS;

EID: 84958259484     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370215579013     Document Type: Article

References (45)

1. M.G.FuryE.ShermanA.L.HoH.XiaoF.TsaiO.NwankwoC.SimaA.HeguyN.KatabiS.HaqueD.G.Pfister. A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer. Cancer2013; 119: 1823–31.
2. S.NicholsonE.HallS.J.HarlandJ.D.ChesterL.PickeringJ.BarberT.ElliottA.ThomsonS.BurnettC.CruickshankB.CarringtonR.WatersA.Bahl. Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001). Br J Cancer2013; 109: 2554–9.
3. C.MáthéA.BohácsL.DuffekJ.LukácsovitsZ.I.KomlosiK.SzondyI.HorváthV.MüllerG.Losonczy. Cisplatin nephrotoxicity aggravated by cardiovascular disease and diabetes in lung cancer patients. Eur Respir J2011; 3: 888–94.
4. G.P.Stathopoulos. Cisplatin: Process and future. J BUON2013; 18: 564–9.
5. X.YaoK.PanichpisalN.KurtzmanK.Nugent. Cisplatin nephrotoxicity: A review. Am J Med Sci2007; 334: 115–24.
6. T.BoulikasM.Vougiouka. Cisplatin and platinum drugs at the molecular level. (Review). Oncol Rep2003; 10: 1663–82.
7. P.D.Sánchez-GonzálezF.J.López-HernándezJ.M.López-NovoaA.I.Morales. An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity. Crit Rev Toxicol2011; 41: 803–821.
8. R.P.MillerR.K.TadagavadiG.RameshW.B.Reeves. Mechanisms of Cisplatin nephrotoxicity. Toxins (Basel)2010; 2: 2490–518.
9. N.A.dos SantosM.A.Carvalho RodriguesN.M.MartinsA.C.dos Santos. Cisplatin-induced nephrotoxicity and targets of nephroprotection: An update. Arch Toxicol2012; 86: 1233–50.
10. Y.I.ChirinoJ.Pedraza-Chaverri. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol2009; 61: 223–42.
11. J.L.KoynerR.Sher AliP.T.Murray. Antioxidants. Do they have a place in the prevention or therapy of acute kidney injury?. Nephron Exp Nephrol2008; 109: e109–17.
12. N.PablaZ.Dong. Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies. Kidney Int2008; 73: 994–1007.
13. M.H.HaniganD.M.TownsendA.J.Cooper. Metabolism of cisplatin to a nephrotoxin. Toxicology2009; 257: 174–175.
14. B.H.AliM.S.Al Moundhri. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: A review of some recent research. Food Chem Toxicol2006; 44: 1173–83.
15. B.H.AliM.Al-MoundhriM.T.EldinA.NemmarS.Al-SiyabiK.Annamalai. Amelioration of cisplatin-induced nephrotoxicity in rats by tetramethylpyrazine, a major constituent of the Chinese herb Ligusticum wallichi. Exp Biol Med (Maywood)2008; 233: 891–6.
16. B.H.AliS.Al-SalamI.S.Al HusseiniI.Al-LawatiM.WalyJ.YasinM.FahimA.Nemmar. Abrogation of cisplatin-induced nephrotoxicity by emodin in rats. Fundam Clin Pharmacol2013; 27: 192–200.
17. N.Al-KharusiH.A.BabikerS.Al-SalamM.I.WalyA.NemmarI.Al-LawatiJ.YasinS.BeegamB.H.Ali. Ellagic acid protects against cisplatin-induced nephrotoxicity in rats: A dose-dependent study. Eur Rev Med Pharmacol Sci2013; 17: 299–310.
18. Nemmar A, Holme JA, Rosas I, Schwarze PE, Alfaro-Moreno E. Recent advances in particulate matter and nanoparticle toxicology: a review of the in vivo and in vitro studies. Biomed Res Int 2013;2013:279371
19. A.NemmarS.Al-SalamS.ZiaF.MarzouqiA.Al-DhaheriD.SubramaniyanS.DhanasekaranJ.YasinB.H.AliE.E.Kazzam. Contrasting actions of diesel exhaust particles on the pulmonary and cardiovascular systems and the effects of thymoquinone. Br J Pharmacol2011; 164: 1871–1882.
20. Li PK, Burdmann EA, Mehta RL. World Kidney Day Steering Committee 2013. Acute kidney injury: global health alert. Transplantation2013; 95: 653–7.
21. Q.PengL.ZhangY.AiL.Zhang. Epidemiology of acute kidney injury in intensive care septic patients based on the KDIGO guidelines. Chin Med J (Engl)2014; 127: 1820–6.
22. M.A.Perazella. Onco-nephrology: Renal toxicities of chemotherapeutic agents. Clin J Am Soc Nephrol2012; 7: 1713–21.
23. T.K.Burki. Twice as bad: New estimates for mortality from air pollution. Lancet Respir Med2014; 2: 355.
24. R.W.AtkinsonS.KangH.R.AndersonI.C.MillsH.A.Walton. Epidemiological time series studies of PM2.5 and daily mortality and hospital admissions: A systematic review and meta-analysis. Thorax2014; 69: 660–5.
25. B.H.Ali. The effect of Nigella sativa oil on gentamicin nephrotoxicity in rats. Am J Chin Med2004; 32: 49–55.
26. D.ZangY.ShaoX.Li. Ultrastructural pathology of rat lung injury induced by ischemic acute kidney injury. Ultrastruct Pathol2013; 37: 433–9.
27. D.J.Pierson. Respiratory considerations in the patient with renal failure. Respir Care2006; 51: 413–22.
28. C.C.ChienL.S.KingH.Rabb. Mechanisms underlying combined acute renal failure and acute lung injury in the intensive care unit. Contrib Nephrol2004; 144: 53–62.
29. H.T.HassounM.L.LieD.N.GrigoryevM.LiuR.M.TuderH.Rabb. Kidney ischemia-reperfusion injury induces caspase-dependent pulmonary apoptosis. Am J Physiol Renal Physiol2009; 297: F125–37.
30. F.LadenW.C.Winkelmayer. Air pollution and coronary risk in kidney transplant recipients. Am J Kidney Dis2011; 58: 506–7.
31. M.A.MansourM.N.NagiA.S.El-KhatibA.M.Al-Bekairi. Effects of thymoquinone on antioxidant enzyme activities, lipid peroxidation and DT-diaphorase in different tissues of mice: a possible mechanism of action. Cell Biochem Funct2002; 20: 143–51.
32. B.H.AliG.Blunden. Pharmacological and toxicological properties of Nigella sativa. Phytother Res2003; 17: 299–305.
33. C.C.WooA.P.KumarG.SethiK.H.Tan. Thymoquinone: Potential cure for inflammatory disorders and cancer. Biochem Pharmacol2012; 83: 443–51.
34. I.Ö.AycanA.TüfekO.TokgözO.EvliyaoğluU.FıratG.Ö.KavakH.TurgutM.U.Yüksel. Thymoquinone treatment against acetaminophen-induced hepatotoxicity in rats. Int J Surg2014; 12: 213–8.
35. T.BaiY.YangY.L.WuS.JiangJ.J.LeeL.H.LianJ.X.Nan. Thymoquinone alleviates thioacetamide-induced hepatic fibrosis and inflammation by activating LKB1-AMPK signaling pathway in mice. Int Immunopharmacol2014; 19: 351–7.
36. B.H.AliS.Al SalamM.Al Za'abiK.Al BalushiA.S.AlMahruqiS.BeegamI.Al-LawatiaM.I.WalyA.Nemmar. Renoprotective effects of gamma-aminobutyric acid (GABA) on cisplatin-induced acute renal injury in rats. Basic Clin Pharmacol Toxicol2015; 35: 29–37.
37. D.Esteban-FernándezJ.M.VerdaguerR.Ramírez-CamachoM.A.PalaciosM.M.Gómez-Gómez. Accumulation, fractionation, and analysis of platinum in toxicologically affected tissues after cisplatin, oxaliplatin, and carboplatin administration. J Anal Toxicol2008; 32: 140–6.
38. A.M.AbdelrahmanS.Al SalamA.S.AlMahruqiI.S.Al husseniM.A.MansourB.H.Ali. N-acetylcysteine improves renal hemodynamics in rats with cisplatin-induced nephrotoxicity. J Appl Toxicol2010; 30: 15–21.
39. B.H.AliA.M.AbdelrahmanS.Al-SalamM.SudhadeviA.S.AlMahruqiI.S.Al-HusseniS.BeegamS.DhanasekaranA.NemmarM.Al-Moundhri. The effect of sildenafil on cisplatin nephrotoxicity in rats. Basic Clin Pharmacol Toxicol2011; 109: 300–8.
40. C.L.Do AmaralH.D.FrancescatoT.M.CoimbraR.S.CostaJ.D.DarinL.M.AntunesL.Bianchi Mde. Resveratrol attenuates cisplatin-induced nephrotoxicity in rats. Arch Toxicol2008; 82: 363–70.
41. A.NemmarS.BeegamP.YuvarajuJ.YasinM.A.FahimE.E.KazzamI.AlhaddabiB.H.Ali. Potentiation of cisplatin-induced nephrotoxicity by repeated exposure to diesel exhaust particles: An experimental study in rats. Exp Biol Med (Maywood)2014; 239: 1036–44.
42. B.D.SahuA.K.KalvalaM.KoneruJ.Mahesh KumarM.KunchaS.S.RachamallaR.Sistla. Ameliorative effect of fisetin on cisplatin-induced nephrotoxicity in rats via modulation of NF-κB activation and antioxidant defence. PLoS One2014; 9: e105070.
43. Y.LiuH.K.WebbH.FukushimaJ.MicheliS.MarkovaJ.L.OlsonD.L.Kroetz. Attenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor κB signaling. J Pharmacol Exp Ther2012; 341: 725–34.
44. A.L.Al-MalkiA.A.Sayed. Thymoquinone attenuates cisplatin-induced hepatotoxicity via nuclear factor kappa-β. BMC Complement Altern Med2014; 14: 282.
45. S.R.GalalyO.M.AhmedA.M.Mahmoud. Thymoquinone and curcumin prevent gentamicin-induced liver injury by attenuating oxidative stress, inflammation and apoptosis. J Physiol Pharmacol2014; 65: 823–32.